Dash Bio

Automates lab assays in drug discovery, with robots and software taking over manual scientist tasks like sample preparation and test execution. Co-founder Dave Johnson is Moderna's former Chief Data and AI Officer. He says Dash completes assays in days, about 10x the industry standard. The company has dozens of customers with fixed, publicly listed pricing, eliminating lengthy sales cycles. Cumulative funding US$47.5M.

City

—

Founded

—

Ticker

Unlisted

Website

—